A technical overview of technegas as a lung ventilation agent
Technegas is a carbon-based nanoparticle developed in Australia in 1984 and has been in
widespread clinical use, including SPECT imaging, since 1986. Although 81mKr offers the …
widespread clinical use, including SPECT imaging, since 1986. Although 81mKr offers the …
Ventilation Scintigraphy With Radiolabeled Carbon Nanoparticulate Aerosol (Technegas): State-of-the-Art Review and Diagnostic Applications to Pulmonary …
PY Le Roux, WM Schafer, F Blanc-Beguin… - Clinical nuclear …, 2023 - journals.lww.com
Invented and first approved for clinical use in Australia 36 years ago, Technegas is the
technology that enabled ventilation scintigraphy with 99m Tc-labeled carbon nanoparticles …
technology that enabled ventilation scintigraphy with 99m Tc-labeled carbon nanoparticles …
Aerosols for therapy and diagnosis
MJ O'Doherty, RF Miller - European journal of nuclear medicine, 1993 - Springer
Aerosols are defined as any mixture of solid or liquid particles/droplets that are stable as a
suspension in air. Aerosols influence the lives of a large majority of the population. A …
suspension in air. Aerosols influence the lives of a large majority of the population. A …
Evaluation of lung clearance of inhaled pertechnegas
S Fanti, G Compagnone, D Pancaldi, R Franchi… - Annals of nuclear …, 1996 - Springer
Pertechnegas is a new ventilation agent produced by modifying the atmosphere of
combustion of Technegas. Due to its rapid disappearance from the lungs, Pertechnegas has …
combustion of Technegas. Due to its rapid disappearance from the lungs, Pertechnegas has …
Technegas-99mTc-metal core graphite nanoparticles for pulmonary ventilation imaging
LI Wiebe, WM Burch… - Current …, 2010 - ingentaconnect.com
Technegas, a carbon-coated Tc-99m nanoparticulate aerosol invented by Burch at the
Australian National University in 1984, was introduced to the medical community in 1986 …
Australian National University in 1984, was introduced to the medical community in 1986 …